NCT04725539

Brief Summary

Mountain sport activities as for example hiking or skiing may involve the risk of adverse health events especially in older people not accustomed to the specific mountain sport at altitude or people with pre-existing health issues. Increased activation of the sympathetic nervous system and abrupt changes in heart rate and blood pressure are thought to trigger these adverse effects. Preventive measures include regular physical activity (i.e. training) and adequate medical treatment. Hypoxia pre-adaptation (e.g., pre-adapt one night at moderate altitude) and pre-conditioning (e.g., intermittent hypoxia (IH) training), which was shown to lead to some favorable sympathetic nervous system, ventilatory and metabolic adaptations and additionally exerts anti-inflammatory action, could be hypothesized of being a further preventive measure. The aim of this research project is to investigate whether intermittent hypoxia pre-conditioning or sleeping one night at altitude (i.e., current recommendation before practicing mountain leisure sports in the elderly) is able to increase oxygen saturation during passive hypoxia exposure and during simulated hiking and skiing at altitude. Additionally, it is aimed to investigate whether such procedure reduces the physiological responses (i.e., heart rate, its variability and blood pressure (including baroreflex sensitivity) responses as well as metabolic, ventilatory, inflammatory and redox responses) during these activities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 8, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 26, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

August 12, 2025

Status Verified

August 1, 2025

Enrollment Period

2.8 years

First QC Date

January 8, 2021

Last Update Submit

August 7, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Resting oxygen saturation (%) at altitude

    Resting oxygen saturation changes after the pre-conditioning and pre-adaptation program at 3000 m altitude

    Through study completion, an average of 1.5 years

  • Oxygen saturation during exercise at altitude

    Oxygen saturation during exercise changes after the pre-conditioning and pre-adaptation program at 3000 m altitude

    Through study completion, an average of 1.5 years

Secondary Outcomes (7)

  • Heart rate (bpm) responses during rest and during exercise at altitude

    Through study completion, an average of 1.5 years

  • Blood pressure (mmHg) responses during rest and during exercise at altitude

    Through study completion, an average of 1.5 years

  • Changes of inflammatory markers (i.e., hsCRP) from before to after the pre-conditioning and pre-adaptation program

    Through study completion, an average of 1.5 years

  • Changes of physiological stress markers (i.e., catecholamine) from before to after the pre-conditioning and pre-adaptation program

    Through study completion, an average of 1.5 years

  • Changes in heart rate variability (HRV) from before to after the pre-conditioning and pre-adaptation program

    Through study completion, an average of 1.5 years

  • +2 more secondary outcomes

Study Arms (2)

Intermittent hypoxia (IH) pre-conditioning

EXPERIMENTAL

The IH pre-conditioning program will be performed in a sitting position by inhaling a gas mixture with reduced O2 content via face masks.The program will include five sessions per week for 3 weeks. Each session consists of three to five hypoxic (14-10% inspired fraction of oxygen) periods, each lasting 3-5 min with 3-min normoxic intervals. The control setting includes breathing room air via face mask.

Procedure: hypoxic exposure

Hypoxia pre-adaptation

EXPERIMENTAL

The hypoxia pre-adaptation program consists of sleeping 1 night at 1900m. The control setting includes sleeping 1 night close to sea level.

Procedure: hypoxic exposure

Interventions

Administration of different hypoxic doses. Intermittent hypoxia: days 1-5 duration of breathing periods 5\*3min (FiO2 14-21%) days 8-12 duration of breathing periods 4\*4min (FiO2 = 12%) and 3\*3 min (FiO2 = 21%) days 15-19 duration of breathing periods 5\*5min (FiO2 = 10%) and 4\*3 min (FiO2 = 21%) one night at 1900m

Hypoxia pre-adaptationIntermittent hypoxia (IH) pre-conditioning

Eligibility Criteria

Age50 Years - 70 Years
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will include normally physically active males and females (age 50-70 years; New York Heart Association (NYHA) class I and II) with or without prior myocardial infarction, living \<600 m.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eurac Research

Bolzano, BZ, 39100, Italy

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Hannes Gatterer, PhD

    Institute of Mountain Emergency Medicine, EURAC Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2021

First Posted

January 26, 2021

Study Start

January 1, 2022

Primary Completion

October 31, 2024

Study Completion

October 31, 2024

Last Updated

August 12, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Data underlying scientific publications will be stored in open repositories (accessible).

Shared Documents
STUDY PROTOCOL
Time Frame
After publications
Access Criteria
The data that support the findings of this study are available from the corresponding author upon reasonable request.

Locations